Suppression of Tumorigenicity of Human Prostate Cancer Cells by Introduction of Human Chromosome del(12)(q13)

Cancer Research

Volumn 54, Issue 12, 1994, Pages 3077-3081

  Bérubé, Nathalie G ^a   Speevak, Marsha D ^a   Chevrette, Mario ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; HYGROMYCIN B;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL FUSION; CHROMOSOME 12; CHROMOSOME 3; CHROMOSOME DELETION; HUMAN; HUMAN CELL; HYBRID CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

ANIMAL; CELL FUSION; CHROMOSOMES, HUMAN, PAIR 12; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HUMAN; HYBRID CELLS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; PHENOTYPE; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028239486     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fearon, E.R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
2. Vogelstein, B., Fearon, E.R., Kern, S.E., Hamilton, S.R., Preisinger, A.C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244: 207-211, 1989.
3. Baker, S.J., Fearon, E.R., Kern, S.E., Hamilton, S.R., Preisinger, A.C., Jessup, J.M., van Tuinen, P., Ledbetter, D.H., Barker, D.F., Nakamura, Y., White, R., and Vogelstein, B. Chromosome 17 deletions and p. 3 gene mutations in colorectal carcinomas. Science (Washington DC), 244: 217-221, 1990.
4. Groden, J., Thliveris, A., Samowitz, W., et al Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66: 589-600, 1991.
5. Fearon, E.R., Cho, K.R., Nigro, J.M., Kern, S.E., Simons, J.W., Ruppert, J.M., Hamilton, S.R., Preisinger, A.C., Thomas, G., Kinzler, K.W., and Vogelstein, B. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (Washington DC), 247: 49-56 1990.
6. Bergerheim, U.S.R., Kunimi, K., Collins, V.P., and Ekman, P. Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes Cancer, 3: 215-220, 1991.
7. Gao, X., Honn, K.V., Grignon, D., Sakr, W., and Chen, Y.Q. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res., 53: 2723-2727, 1993.
8. Stanbridge, E.J., Flandermeyer, R.F., Daniels, D.W., and Nelson-Rees, W.A. Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids. Somatic Cell Genet., 7: 699-712, 1981.
9. Trent, J.M., Stanbridge, E.J., McBride, H.L., Meese, E.U., Casey, G., Araujo, D.E., Witkowski, C.M., and Nagle, R.B. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science (Washington DC), 247: 568-571, 1990.
10. Lupton, S.D., Brunton, L.L., Kalberg, V.A., and Overell, R.W. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol., 11: 3374-3378, 1991.
11. Banerjee, A., Xu, H.J., Hu, S.X., Araujo, D., Takahashi, R., Stanbridge, E.J., and Benedict, W.F. Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13. Cancer Res., 52: 6297-6304, 1992.
12. Fournier, R.E.K. A general high-efficiency procedure for production of microcell hybrids. Proc. Nati. Acad. Sci. USA, 78: 6349-6353, 1981.
13. Rizzino, A. Soft agar growth assays for transforming growth factors and mitogenic peptides. Methods Enzymol., 146: 341-352, 1987.
14. Dorin, J.R., Emslie, E., Hanratty, D., Farrall, M., Gosden, J., and Porteous, D.J. Gene targeting for somatic cell manipulation: rapid analysis of reduced chromosome hybrids by Alu-PCR fingerprinting and chromosome painting. Hum. Mol. Genet., 1: 53-59, 1992.
15. Bookstein, R., Rio, P., Madreperla, S., Hong, F., Allred, C., Grizzle, W.E., and Lee, W.H. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad. Sci. USA, 87: 7762-7766, 1990.
16. Bookstein, R., Shew, J.Y., Chen, P.L., Scully, P., and Lee, W.H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (Washington DC), 247: 712-715, 1990.
17. Isaacs, W.B., Carter, B.S., and Ewing, C.M. Wild-type p. 3 suppresses growth of human prostate cancer cells containing mutant p. 3 alleles. Cancer Res., 51: 4716-4720, 1991.
18. Kugoh, H.M., Hashiba, H., Shimizu, M., and Oshimura, M. Suggestive evidence for functionally distinct, tumor suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080. Oncogene, 5: 1637-1644, 1990.
19. Peltomäki, P., Aaltonen, L.A., Sistonen, P., et al Genetic mapping of a locus predisposing to human colorectal cancer. Science (Washington DC), 260: 810-812, 1993.
20. Mitelman, F., Kaneko, Y., and Trent, J. Report of the committee on chromosome changes in neoplasia. Cytogenet. Cell Genet., 58: 1053-1079, 1991.